EGLN2 and Chronic colitis: Consistent with the protective effects of Phd1 deficiency against chronic colitis, Phd1–/– mice displayed a significantly reduced tumor number and size compared with WT controls (Figure 2, A and B, and Supplemental Figure 2A).